Frazier Lifesciences Acquisition's other liabilities is $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Frazier Lifesciences Acquisition (FLAC) currently reports a other liabilities of $0 as of September 2022. In the prior-year period, the figure was $0. Use the charts on this page to explore Frazier Lifesciences Acquisition's other liabilities history and peer comparisons.
Frazier Lifesciences Acquisition's other liabilities changed from $0 to $0 (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Frazier Lifesciences Acquisition reported $0 in other liabilities as of September 2022. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current other liabilities of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Frazier Lifesciences Acquisition, and consider following FLAC for alerts when major investors trade the stock.